Sudarshan Pharma Industries Quarterly Results for Trading Insights

In Sept 2025, Sudarshan Pharma Industries (SUDARSHAN) reported revenue ₹171 Cr and net profit ₹4 Cr — revenue +32.6% YoY. For annual financials, live price and key ratios, visit SUDARSHAN company profile.

Latest Quarter Net Profit
₹4 Cr
QSept 2025
Quarterly Results

SUDARSHAN Quarterly Results — Revenue, Profit & EPS Highlights

Sudarshan Pharma Industries latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with SUDARSHAN fundamental valuation to assess whether the stock is under or overvalued.

  • Revenue of ₹171 Cr in Sept 2025 (+5.6% vs Mar 2025, +32.6% vs Sept 2024)
  • Net Profit of ₹4 Cr in Sept 2025 (-42.9% vs Mar 2025, -33.3% vs Sept 2024)
  • EBITDA of ₹11 Cr in Sept 2025 (-26.7% vs Mar 2025)
  • Operating Margin of 5.0% in Sept 2025 (-4.0pp vs Mar 2025)
  • Earnings Per Share of ₹0.16 in Sept 2025 (-48.4% vs Mar 2025)

Sudarshan Pharma Industries Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SUDARSHAN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 171 162 147 170 129 5.6% 32.6%
Net Profit (₹ Cr) 4 7 4 4 6 - -
EBITDA (₹ Cr) 11 15 12 12 12 - -
EPS (₹) 0.16 0.31 0.16 0.18 0.24 - -
Operating Margin (%) 5.0% 9.0% 8.0% 6.0% 9.0% - -

SUDARSHAN Share Price Trend — 1-Year Movement Across Quarterly Results

Sudarshan Pharma Industries 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse Sudarshan Pharma Industries shareholding analysis to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 2.3%
EBITDA Margin 6.4%
Operating Margin 5.0%
ROE (Annual) 12.1%

Balance Sheet Highlights

Total Assets ₹402 Cr
Total Equity ₹132 Cr
Current Assets ₹335 Cr
Current Liabilities ₹11 Cr

Cash Flow Analysis

Operating Cash Flow ₹35 Cr
Investing Cash Flow ₹-20 Cr
Financing Cash Flow ₹-14 Cr
Net Cash Flow ₹0 Cr

Revenue Trend (₹ Cr)

Dec 2025 170
Jun 2025 147
Mar 2025 162
Sept 2025 171

Net Profit Trend (₹ Cr)

Dec 2025 4
Jun 2025 4
Mar 2025 7
Sept 2025 4

Operating Margin Trend (%)

Dec 2025 6.0%
Jun 2025 8.0%
Mar 2025 9.0%
Sept 2025 5.0%

SUDARSHAN vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Sudarshan Pharma Industries latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Sept 2025 		₹138,121.06 Cr 1326.5 3,605 585 +11.9% - 16.2% 233.1
SRF
Sept 2025 		₹73,317.72 Cr 2443.2 3,560 388 -16.2% - 10.9% 186.5
Coromandel Internat…
Sept 2025 		₹61,764.26 Cr 2093.6 9,771 793 +78.9% - 8.1% 76.6
Linde
Sept 2025 		₹61,319.36 Cr 7240.0 650 171 +7.4% - 26.3% 361.1
Fertilisers & Chemi…
Sept 2025 		₹55,492.89 Cr 852.4 1,681 21 +48.8% - 1.2% 2663.6
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores